Company intelligence / Profile preview

Prasfarma

Manlleu, Catalonia / Barcelona Province, Spainprasfarma.com ↗

Ownership: Private
Employees: ~34
Development stage: Other

Overview

Prasfarma is an established pharmaceutical CMO/CDMO specializing in the development and manufacturing of cytostatics, highly potent APIs, biologics, and injectable/solid forms. The company offers end-to-end services from early R&D to commercial supply with state-of-the-art technologies including freeze drying adapted to Annex 1 standards. It has over 80 years of experience and serves more than 65 countries globally.

Therapeutic areas: Oncology
Modalities: Small moleculeBiologicAntibody-drug conjugateMonoclonal antibodymRNA-based drugsProtein vaccineLive viral vaccineViral vector vaccinePlasmid DNA therapyCell therapy
Industry: Contract Manufacturing Organization

Partnerships

Collaborates with start-ups, universities, research groups, pharma companies as a contract manufacturer/developer

Beyond the preview

Go deeper on Prasfarma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prasfarma.

Explore the full profile